Anders Lehmann

CSO at Stayble Therapeutics

Anders has broad experience in drug discovery and development from AstraZeneca with a wide international network, and experience from start-ups and spin-outs, one of which he co-founded. He has acted internationally as a consultant for both large pharma companies and biotechs. Anders has an extensive experience in managing both preclinical and clinical drug development projects.

Links

Previous companies

Oncorena AB logo
AstraZeneca logo

Timeline

  • CSO

    Current role

View in org chart